BusinessGeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development PlatformBy Nasdaq OMXMay 30, 2017, 11:03 AM UTC
BusinessGeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development PlatformBy Nasdaq OMXMay 30, 2017, 11:03 AM UTC
BusinessActinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Actimab-ABy Nasdaq OMXMay 24, 2017, 1:26 PM UTC
BusinessActinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Actimab-ABy Nasdaq OMXMay 24, 2017, 1:26 PM UTC
BusinessActinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Actimab-ABy Nasdaq OMXMay 24, 2017, 1:26 PM UTC
BusinessActinium Pharmaceuticals to Present Actimab-A Data at the 10th International Symposium on Targeted Alpha TherapyBy Nasdaq OMXMay 23, 2017, 11:32 AM UTC
BusinessActinium Pharmaceuticals to Present Actimab-A Data at the 10th International Symposium on Targeted Alpha TherapyBy Nasdaq OMXMay 23, 2017, 11:32 AM UTC